Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 May;38(5):1209–1210. doi: 10.1128/aac.38.5.1209

Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy.

J L Gaillard 1, V Abadie 1, G Cheron 1, F Lacaille 1, B Mahut 1, C Silly 1, V Matha 1, C Coustere 1, F Lokiec 1
PMCID: PMC188183  PMID: 8067769

Abstract

The penetration of ceftriaxone into cerebrospinal fluid (CSF) was studied with 11 children (mean age: 2 years, 4 months; range: 4 months to 8 years) with meningitis, receiving dexamethasone (0.15 mg/kg of body weight intravenously four times daily) as adjunctive therapy. Ceftriaxone was given intravenously at doses of 50 mg/kg twice daily to patients < 18 months old and 100 mg/kg once daily to patients > or = 18 months old. CSF was collected after 1 day of treatment at the expected peak concentration of ceftriaxone in CSF. Concentrations of ceftriaxone in CSF ranged from 0.7 to 9.2 mg/liter, with a mean value of 4.0 (standard deviation [SD], 2.9) mg/liter. Values were significantly higher for patients with CSF glucose levels of < 1 mmol/liter on admission to the hospital than for patients with CSF glucose levels of > or = 1 mmol/liter (mean values of 7.1 [SD, 2.2] mg/liter versus 2.2 [SD, 1.1] mg/liter; P < 0.001). After 1 day of treatment, ceftriaxone concentrations in the CSF of children receiving dexamethasone are similar to the mean values reported for children not treated with dexamethasone.

Full text

PDF
1209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barling R. W., Selkon J. B. The penetration of antibiotics into cerebrospinal fluid and brain tissue. J Antimicrob Chemother. 1978 May;4(3):203–227. doi: 10.1093/jac/4.3.203. [DOI] [PubMed] [Google Scholar]
  2. Brady M. T., Kaplan S. L., Taber L. H. Association between persistence of pneumococcal meningitis and dexamethasone administration. J Pediatr. 1981 Dec;99(6):924–926. doi: 10.1016/s0022-3476(81)80023-6. [DOI] [PubMed] [Google Scholar]
  3. Cherubin C. E., Eng R. H., Norrby R., Modai J., Humbert G., Overturf G. Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis. 1989 Jul-Aug;11(4):526–548. doi: 10.1093/clinids/11.4.526. [DOI] [PubMed] [Google Scholar]
  4. Latif R., Dajani A. S. Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis. Antimicrob Agents Chemother. 1983 Jan;23(1):46–48. doi: 10.1128/aac.23.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lebel M. H., McCracken G. H., Jr Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989 Feb;83(2):161–167. [PubMed] [Google Scholar]
  6. Martin E., Koup J. R., Paravicini U., Stoeckel K. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J Pediatr. 1984 Sep;105(3):475–481. doi: 10.1016/s0022-3476(84)80032-3. [DOI] [PubMed] [Google Scholar]
  7. McCracken G. H., Jr Current management of bacterial meningitis in infants and children. Pediatr Infect Dis J. 1992 Feb;11(2):169–174. doi: 10.1097/00006454-199202000-00036. [DOI] [PubMed] [Google Scholar]
  8. Mustafa M. M., Ramilo O., Mertsola J., Risser R. C., Beutler B., Hansen E. J., McCracken G. H., Jr Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis. 1989 Nov;160(5):818–825. doi: 10.1093/infdis/160.5.818. [DOI] [PubMed] [Google Scholar]
  9. Mustafa M. M., Ramilo O., Sáez-Llorens X., Olsen K. D., Magness R. R., McCracken G. H., Jr Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child. 1990 Aug;144(8):883–887. doi: 10.1001/archpedi.1990.02150320047024. [DOI] [PubMed] [Google Scholar]
  10. Odio C. M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., Sáez-Llorens X., Olsen K. D., McCracken G. H., Jr The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991 May 30;324(22):1525–1531. doi: 10.1056/NEJM199105303242201. [DOI] [PubMed] [Google Scholar]
  11. Scheld W. M., Brodeur J. P. Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother. 1983 Jan;23(1):108–112. doi: 10.1128/aac.23.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sáez-Llorens X., Ramilo O., Mustafa M. M., Mertsola J., McCracken G. H., Jr Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr. 1990 May;116(5):671–684. doi: 10.1016/s0022-3476(05)82647-2. [DOI] [PubMed] [Google Scholar]
  13. Tunkel A. R., Wispelwey B., Scheld W. M. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med. 1990 Apr 15;112(8):610–623. doi: 10.7326/0003-4819-112-8-610. [DOI] [PubMed] [Google Scholar]
  14. del Rio M. A., Chrane D., Shelton S., McCracken G. H., Jr, Nelson J. D. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet. 1983 Jun 4;1(8336):1241–1244. doi: 10.1016/s0140-6736(83)92696-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES